Eli Lilly & Co. (LLY)

Sector:Health Care
Super Investor Stats:
Ownership count:6
Ownership rank:70
% of all portfolios:0.075%
Hold Price * :$626.72
History Portfolio Manager Activity Share change % change to portfolio
Q4  2023
Chase Coleman - Tiger Global Management Reduce 3.17% 29,100 0.12
Polen Capital Management Reduce 4.65% 29,011 0.01
Mairs & Power Growth Fund Reduce 8.12% 11,000 0.13
Q3  2023
Mairs & Power Growth Fund Reduce 16.33% 26,461 0.32
Q2  2023
Mairs & Power Growth Fund Reduce 19.00% 38,000 0.37
Q4  2022
Francois Rochon - Giverny Capital Sell 100.00% 432 0.01
Q3  2022
Mairs & Power Growth Fund Reduce 8.55% 13,000 0.10
Q2  2022
Mairs & Power Growth Fund Reduce 40.39% 103,000 0.75
Q4  2021
Lee Ainslie - Maverick Capital Sell 100.00% 3,331 0.01
Q4  2020
Lee Ainslie - Maverick Capital Sell 100.00% 5,349 0.01
Q2  2020
Mairs & Power Growth Fund Reduce 23.66% 79,031 0.31
Q1  2020
Mairs & Power Growth Fund Reduce 4.30% 15,000 0.06
Dodge & Cox Sell 100.00% 5,012,119 0.89
Q4  2019
Dodge & Cox Reduce 9.73% 540,000 0.10
Q2  2019
Dodge & Cox Reduce 38.42% 3,464,700 0.56
Q1  2019
Dodge & Cox Reduce 1.57% 143,400 0.03
Mairs & Power Growth Fund Reduce 29.34% 90,969 0.27
Q4  2018
Mairs & Power Growth Fund Reduce 21.52% 85,000 0.25
Dodge & Cox Reduce 34.10% 4,740,300 0.91
Hillman Value Fund Sell 100.00% 12,200 4.07
Q3  2018
Mairs & Power Growth Fund Reduce 14.13% 65,000 0.15
Dodge & Cox Reduce 16.10% 2,667,900 0.39
Q4  2017
Dodge & Cox Reduce 0.53% 64,000 0.01
Q2  2009
Bill & Melinda Gates Foundation Trust Sell 100.00% 938,000 0.39

* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.